Company intelligence / Profile preview

Breathe BioMedical

Moncton, New Brunswick, Canadabreathebiomedical.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Recent research identified differences in breath signatures of women with early-stage breast cancer compared to those without breast cancer with 88.2% accuracy. A sub-group analysis found that breast tissue density had no significant effect on accuracy.

Therapeutic areas: OncologyOther
Modalities: Breath analyticsDiagnostic technology
Industry: Metabolite Diagnostics

Partnerships

George Washington University Breast Center

Beyond the preview

Go deeper on Breathe BioMedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Breathe BioMedical.

Explore the full profile